Cost-effectiveness of dehydrated human amnion/chorion membrane allografts in lower extremity diabetic ulcer treatment
Authors
William H. Tettelbach, MD, FACP, FIDSA, FUHM, FAPWCS, CWS¹ ² ³ ⁴ ⁵ ⁶*
David G. Armstrong, MD, PhD, DPM, MS⁷ ⁸
Thomas J. Chang, DPM⁹
Julie L. De Jong, MS¹
Paul M. Glat, MD, FACS¹⁰
Jeffrey H. Hsu, MD, FACS¹¹
Martha R. Kelso, RN, LNC, HBOT¹²
Jeffrey A. Niezgoda, MD, FACHM, MAPWCA, CHWS¹³
Jonathan M. Labovitz, DPM, FACFAS, CHCQM²
Brandon Hubbs, MA, MS¹
R. Allyn Forsyth, PhD¹ ¹⁴
Benjamin G. Cohen, PhD, MPH¹⁵
Natalie M. Reid, PhD, MPH, MBA¹⁵
William V. Padula, PhD, MS¹⁵ ¹⁶ ¹⁷ ¹⁸
Corresponding Author: btettelbach@mimedx.com
Affiliations
¹ MIMEDX Group, Inc., US.
² College of Podiatric Medicine, Western University of Health Sciences, US.
³ Duke University School of Medicine, Department of Anesthesiology, US.
⁴ Association for the Advancement of Wound Care.
⁵ Western Peaks Specialty Hospital, US.
⁶ Encompass Health & Rehabilitation Hospital of Utah, US.
⁷ Southwestern Academic Limb Salvage Alliance (SALSA).
⁸ Keck School of Medicine, University of Southern California, Department of Surgery, US.
⁹ Redwood Orthopedic Surgery Associates, US.
¹⁰ Saint Christopher’s Hospital, US.
¹¹ Kaiser Permanente Southern California, US.
¹² Wound Care Plus, LLC, US.
¹³ AZH Wound & Vascular Centers, US.
¹⁴ Department of Biology, San Diego State University, San Diego, California, US.
¹⁵ Monument Analytics, Baltimore, MD, US.
¹⁶ Department of Pharmaceutical & Health Economics, School of Pharmacy, University of Southern California, Los Angeles, CA, US.
¹⁷ The Leonard D. Schaeffer Center for Health Policy & Economics, University of Southern California, Los Angeles, CA, US.
¹⁸ Department of Acute & Chronic Care, Johns Hopkins School of Nursing, Baltimore, MD, US.
